Claiborne Cary J

Avg. Two Year Performance

No purchase track record
(24%) Avg. Sale Return
(12%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return1%10%(32%)(89%)0%
Purchase Success Rate1 of 11 of 10 of 10 of 10 of 1
Average Sale Return(3%)(30%)(15%)(30%)(24%)
Sale Success Rate3 of 43 of 43 of 41 of 40 of 4
Chemicals » Specialty Chemicals

former CEO, CFO & Pres., Director:

Holdings: 435.7K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Executive Officer, Director:

Holdings: 1.52M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Other

:

Holdings: 2.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--